Markus Queisser
Scientific Director, Protein Degradation, GSK
Markus Queisser is listed as Scientific Director, Protein Degradation, GSK. B2DB records 2 sessions at 1 conference in 2026, most recently Drug Discovery Chemistry Europe 2026 (November 2026). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Markus. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Markus got fascinated by the process of protein degradation early on during his Master’s thesis at Free University in Berlin, where he worked on proteasomal functions and ubiquitin-binding proteins. He further gained broad knowledge in respiratory diseases, inflammation, and oncology while pursuing a Ph.D. in molecular biology and medicine of the lung in Germany and at Albert Einstein College of Medicine in New York. He moved on to a postdoctoral fellowship at Northwestern University in Chicago, where in collaboration with Noble Laureate Aaron Ciechanover, he discovered a hypoxia-regulated ubiquitin-ligase. Prior to joining GSK, he specialized in ubiquitin-ligase recruitment in ER-associated protein degradation at the Ludwig Institute for Cancer Research in Oxford. Currently, he is Scientific Director in the Protein Degradation Group, leading the technology team and leading multiple collaborations with biotech and academia.
Sessions at 1 conference
Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026
- Chairperson's Remarks: Tools For Developing Next-Gen Degraders Chair · 12 November 2026
- TRIM21 E3 Ligase as a Platform for PROTACs and Molecular Glues Speaker · 12 November 2026
Others from GSK
- Sam M. Rowe Investigator 2 sessions
- Shobie Ramakrishnan Chief Digital and Technology Officer 2 sessions
- Andrea Gamir Morralla Principal Investigator 1 session
- Anthony Rowe VP Onyx Research 1 session
- David Egan Assistant General Counsel, Global Digital and Privacy 1 session
- Ian Wall Head Molecular Design 1 session
- Jeffrey T. Hamilton Head, Payer Partnership & Policy - Global Pricing and Market Access 1 session
- Juergen Loskutov Scientific Leader, Bio Bank 1 session
- Libby Hamson Global Pricing and Market Access Director 1 session
- Luke Bellamy Director MSAT Systems & Informatics - Global Manufacturing Science & Technology 1 session
- Patricia Pujol Medical Affairs Manager 1 session
- Tim Ashlin Team Leader and Principal Investigator 1 session